TW202400144A - 登革熱病毒感染之治療及/或預防 - Google Patents

登革熱病毒感染之治療及/或預防 Download PDF

Info

Publication number
TW202400144A
TW202400144A TW112116717A TW112116717A TW202400144A TW 202400144 A TW202400144 A TW 202400144A TW 112116717 A TW112116717 A TW 112116717A TW 112116717 A TW112116717 A TW 112116717A TW 202400144 A TW202400144 A TW 202400144A
Authority
TW
Taiwan
Prior art keywords
days
compound
kcal
fat
day
Prior art date
Application number
TW112116717A
Other languages
English (en)
Chinese (zh)
Inventor
奧利佛 阿克爾特
崔斯坦 巴格特
克蕾兒 波曼
尼爾 戈維爾茲
塔拉斯娜 古勒爾莫 赫蕊拉
迪姆菲 杭特詹斯
芙蕾雅 萊舒爾特
布朗 舒羅彥
伊凡 索莫斯
Original Assignee
美商健生醫藥公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 美商健生醫藥公司 filed Critical 美商健生醫藥公司
Publication of TW202400144A publication Critical patent/TW202400144A/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/4045Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TW112116717A 2022-05-12 2023-05-05 登革熱病毒感染之治療及/或預防 TW202400144A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US202263341074P 2022-05-12 2022-05-12
US63/341,074 2022-05-12
WOPCT/IB2023/054527 2023-05-01
PCT/IB2023/054527 WO2023218285A1 (en) 2022-05-12 2023-05-01 Treatment or prevention of dengue viral infection

Publications (1)

Publication Number Publication Date
TW202400144A true TW202400144A (zh) 2024-01-01

Family

ID=86558745

Family Applications (1)

Application Number Title Priority Date Filing Date
TW112116717A TW202400144A (zh) 2022-05-12 2023-05-05 登革熱病毒感染之治療及/或預防

Country Status (8)

Country Link
US (1) US20250281457A1 (enExample)
EP (1) EP4522163A1 (enExample)
JP (1) JP2025517683A (enExample)
CN (1) CN119173261A (enExample)
AU (1) AU2023269343A1 (enExample)
CA (1) CA3257185A1 (enExample)
TW (1) TW202400144A (enExample)
WO (1) WO2023218285A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025253267A1 (en) 2024-06-06 2025-12-11 Janssen Pharmaceuticals, Inc. Combination of mosnodenvir and close analogs with nitd-688 for use in the treatment and prevention of dengue disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20160086B1 (ar) 2015-05-08 2021-08-17 2 Katholieke Univ Leuven Ku Leuven Research And Development مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
CN114980884A (zh) * 2019-11-15 2022-08-30 杨森制药公司 登革热疾病的治疗和预防

Also Published As

Publication number Publication date
JP2025517683A (ja) 2025-06-10
CA3257185A1 (en) 2023-11-16
US20250281457A1 (en) 2025-09-11
AU2023269343A1 (en) 2025-01-02
CN119173261A (zh) 2024-12-20
EP4522163A1 (en) 2025-03-19
WO2023218285A1 (en) 2023-11-16

Similar Documents

Publication Publication Date Title
KR102121329B1 (ko) 테노포비르 및 엠트리시타빈을 포함하는 제약 제제
JP2931409B2 (ja) パラセタモール及びドンペリドンのフィルムコーティング錠
US20030147950A1 (en) Modified release tamsulosin tablets
KR100651110B1 (ko) 테르비나핀을 포함하는 제약학적 조성물 및 그의 용도
CN111278433A (zh) 尼拉帕尼制剂
TW201238612A (en) Therapeutic compositions
US20150150867A1 (en) Compositions of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]piperazine
KR20200037880A (ko) 제약 제제
US20170014340A1 (en) Orally Disintegrating Tablet of Nabilone Comprising Mannitol-Based Granules
AU2012357956A1 (en) Immediate release multi unit pellet system
EP4240331B1 (en) Solid formulation
US20250281457A1 (en) Treatment or prevention of dengue viral infection
TW201834643A (zh) 包含鹽酸依托必利之速釋和緩釋藥物製劑
US20210369624A1 (en) Solid oral dosage form having excellent dissolution properties
CN113164436A (zh) 药物组合物
JP2023071921A (ja) 様々な用量のレナリドミドの経口用錠剤組成物
HK40120143A (zh) 登革热病毒感染的治疗和/或预防
TWI923631B (zh) 固體配製物
US20110262540A1 (en) Solid Pharmaceutical Composition Comprising Exemestane
JPWO2003075919A1 (ja) 塩酸ピルジカイニド含有錠剤(乾式)
JP4866170B2 (ja) 睡眠薬の放出制御医薬組成物及びその製造方法
WO2012148225A2 (en) Sustained-release pharmaceutical composition comprising donepezil or pharmaceutically acceptable salt thereof having improved dissolution stability and method for manufacturing the same
US20250367137A1 (en) Phloroglucinol Formulations And Methods Of Use
HK40099185A (zh) 固体制剂
EP4647130A2 (en) Pharmaceutical composition comprising eliglustat